Assessment of common Nonsteroidal anti-inflammatory medications by whole blood aggregometry: A clinical evaluation for the perioperative setting

World Neurosurgery

Volumn 82, Issue 5, 2014, Pages e633-e638

  Scott, William W ^a   Levy, Michael ^a   Rickert, Kim L ^a   Madden, Christopher J ^a   Beshay, Joseph E ^a   Sarode, Ravi ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

COX 1 inhibitor; COX 2 inhibitor; Nonsteroidal anti inflammatory; Perioperative risk Surgical bleeding; Whole blood platelet aggregometry

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; IBUPROFEN; MELOXICAM; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRAZOLE DERIVATIVE; SULFONAMIDE; THIAZINE DERIVATIVE; THIAZOLE DERIVATIVE;

ADULT; BLEEDING; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DRUG EFFECT; FEMALE; HUMAN; MALE; OPERATIVE BLOOD LOSS; PERIOPERATIVE PERIOD; REVIEW; RISK ASSESSMENT; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; BLOOD LOSS, SURGICAL; CLINICAL TRIAL; DRUG EFFECTS; MIDDLE AGED; NORMAL HUMAN; PROCEDURES; YOUNG ADULT;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD LOSS, SURGICAL; CYCLOOXYGENASE INHIBITORS; FEMALE; HEALTHY VOLUNTEERS; HUMANS; IBUPROFEN; MALE; MIDDLE AGED; NAPROXEN; PERIOPERATIVE CARE; PLATELET AGGREGATION; PYRAZOLES; SULFONAMIDES; THIAZINES; THIAZOLES; YOUNG ADULT;

EID: 84925557054     PISSN: 18788750     EISSN: 18788769     Source Type: Journal    
DOI: 10.1016/j.wneu.2014.03.043     Document Type: Review

References (45)

1. G. Bashein, M.L. Nessly, and A.L. Rice Preoperative aspirin therapy and reoperation for bleeding after coronary artery bypass grafting Arch Int Med 151 1991 89 93
2. A. De Meijer, H. Vollaard, M. de metz, B. Verbruggen, C. Thomas, and I. Novakova Meloxicam, 15 mg/day, spares platelet function in healthy volunteers Clin Pharmacol Ther 66 1999 425 430
3. G.J. Despotis, K.S. Filos, and T.N. Zoys Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients Anesth Analg 82 1996 13 21
4. A.M. Dyszkiewicz-Korpanty, E.P. Frenkel, and R. Sarode Approach to the assessment of platelet function: comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methods Clin Appl Thromb Hemost 11 2005 25 35
5. V.A. Ferraris, and E. Swanson Aspirin usage and perioperative blood loss after hysterectomy Surg Gynecol Obstet 156 1983 439 442
6. M.I. Freed, P.R. Audet, and N. Zariffa Comparative effects of nabumetone, suldinac, and indomethacin on urinary prostaglandin excretion and platelet function in volunteers J Clinic Pharmacol 34 1994 1098 1108
7. C.D. Funk, L.B. Fuk, and M.E. Kennedy Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression and gene chromosomal assignment FASEB J 5 1991 2304 2312
8. A.I. Gavriluk Fibrinolytic hemorrhages in patients with adenomas treated with acetyl salicylate in the pre-operative period Vrach Delo 1 1987 06 98
9. T.T. Horlocker, D.J. Wedel, and D.R. Schroeder Preoperative antiplatelet therapy does not increase the risk of spinal epidural hematoma associated with regional anesthesia Anesth Analg 80 1995 303 309
10. J.Y. Jeremy, D.P. Mikhailidis, M.A. Barradas, R.M. Kirk, and P. Dandona The effect of nabumetone and its principal metabolite on in vitro human gastric mucosal prostanoid synthesis and platelet function Br J Rheumatol 29 1990 116 119
11. P. Kallis, J.A. Tooze, and S. Talbot Pre-operative aspirin decreases platelet aggregation and increases post-operative blood loss: a prospective, randomized, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina Eur J Cardiothorac Surg 8 1994 404 409
12. S.V. Karwande, B.B. Weksler, W.A. Gay, and V.A. Subramanian Effect of preoperative antiplatelet drugs on vascular prostacyclin synthesis Ann Thorac Surg 43 1987 318 322
13. G.N. Kenny Potential renal, hematological and allergic adverse effects associated with Nonsteroidal anti-inflammatory drugs Drugs 44 Suppl 5 1992 31 37
14. T. Klein, R.M. Nusing, J. Pfeilschifter, and V. Ullrich Selective inhibition of cyclooxygenase 2 Biochem Pharmacol 48 1994 1605 1610
15. E.A.J. Knijff-Dutmer, E.M. Kalsbeek-Blatenburg, J. Koertx, and M.A.F.J. van de Laar Platelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclooxygenase-2-selective inhibitors in patients with rheumatoid arthritis Rheumatology 41 2002 458 461
16. E.A.J. Knijff-Dutmer, A. Martens, and M.A.F.J. van de Laar The effect of nabumetone versus naproxen on platelet aggregation in patients with rheumatoid arthritis Ann Rheum Dis 58 1999 257 259
17. R. Langenbach, S.G. Morham, and H.F. Tiano Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration Cell 83 1995 483 492
18. P.T. Leese, R.C. Hubbard, A. Karim, P.C. Isakson, S.S. Yu, and G.S. Geis Effects of celecoxib, a novel cyclkooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial J Clinic Pharmacol 40 2000 124 132
19. C. Li, J. Hirch, C. Xie, M.A. Johnston, and J.W. Eikelboom Reversal of the anti-platelet effects of asprin and clopidogrel J Thromb Hemost 10 2012 521 529
20. B. Lindblad, N.H. Persson, R. Takolander, and D. Bergqvist Does low-dose acetylsalicylic acid prevent stroke after carotid surgery? A double-blind, placebo-controlled randomized trial Stroke 24 1993 1125 1128
21. P.E. Lipsky, S.B. Abramson, and L. Crofford The classification on cyclooxygenase inhibitors J Rheumatol 25 1998 2298 2303
22. D.L. McGlasson, and G.A. Fritsma Whole blood platelet aggregometry and platelet function testing Semin Thromb Hemost 35 2009 168 180
23. N. Matijevic-Aleksic, P. McPhedran, and K.K. Wu Bleeding disorder due to platelet prostaglandin H synthase-1 (PGHS-1) deficiency Br J Hematol 92 1996 212 217
24. L. Menge-Gaw, R.D. Hubbard, and A. Karim A study of the platelet effects of SC-58635, a novel COX-2-selective inhibitor Arthritis Rheum 40 Suppl. 1997 93
25. S.G. Morham, R. Langenbach, and C.D. Loftin Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse Cell 83 1995 473 482
26. D.T. Neilipovitz, G.L. Bryson, and G. Nichol The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis Anesth Analg 93 2001 573 580
27. B. Nunn, and P.D. Chamberlain Effects of nabumetone (BRL 14777), a new anti-inflammatory drug, on human platelet reactivity ex vivo: comparison with naproxen J Pharm Pharmacol 34 1982 576 579
28. J.D. Palmer, O.C. Sparrow, and F. Iannotti Postoperative hematoma: a 5-year survey and identification of avoidable risk factors Neurosurgery 35 1994 1061 1064
29. C. Patrono Aspirin as an antiplatelet drug N Engl J Med 330 1994 1287 2194
30. R.E. Rawitscher, J.W. Jones, T.A. McCoy, and D.A. Lindsley A prospective study of aspirins effect on blood cell loss in cardiac surgery J Cardiovasc Surg 32 1991 1 7
31. P.G. Reasbeck, M.L. Rice, and J.C. Reasbeck Double-blind controlled trial of indomethacin as an adjunct to narcotic analgesia after major abdominal surgery Lancet 2 1982 115 118
32. D.L. Reich, G.C. Patel, and F. Veal-Cantos Aspirin does not increase homologous blood requirements in elective coronary bypass surgery Anesth Analg 79 1994 4 8
33. D. Riendeau, M.D. Percival, and S. Boyce Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor Br J Pharmacol 121 1997 105 117
34. M.G. Rorarius, G.A. Baer, and T. Metsa-Ketela Effects of peri-operatively administered diclofenac and indomethacin on blood loss, bleeding time and plasma prostanoids in man Eur J Anesthesiol 6 1989 335 342
35. S.A. Saeed, M.N. Afzal, and B.H. Shah Dual effects of nimesulide, a COX-2 inhibitor, in human platelets Life Sci 63 1998 1835 1841
36. A.L. Schafer Effects of nonsteroidal anti-inflammatory drugs on platelet function and systemic hemostasis J Clinic Pharmacol 35 1995 209 219
37. K. Schror Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis Semin Thromb Hemost 23 1997 349 356
38. G.K. Sethi, J.G. Copeland, and S. Goldman Implications of pre-operative aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy J Am Coll Cardiol 15 1990 15 20
39. N. Tabuchi, R.C.G. Gallandat Huet, and A. Sturk Hemostatic function of aspirin-treated patients vulnerable to cardio-pulmonary bypass J Thorac Cardiovasc Surg 110 1995 813 818
40. T. Taivain, A. Hiller, P.H. Rosenberg, and O. Neuvonen The effect of continuous intravenous indomethacin infusion on bleeding time and postoperative pain in patients undergoing emergency surgery of the lower extremities Acta Anesthesiol Scand 33 1989 58 60
41. K.J. Tuman, R.J. McCarthy, and C.J. O'Connor Aspirin does not increase allogenic blood transfusion in reoperative coronary artery surgery Anesth Analg 83 1996 1178 1184
42. J.R. Vane, and R.M. Botting Mechanism of action of nonsteroidal anti-inflammatory drugs Am J Med 104 1998 2S 8S
43. A. Vuysteke, A. Oduro, E. Cardan, and R.D. Latimer Effect of aspirin in coronary artery bypass grafting J Cardiothorac Vass Surg 11 1997 831 834
44. C.J.E. Watson, A.M. Deane, P.T. Doyle, and K.N. Bullock Identifiable factors in post-prostatectomy hemorrhage: the role of aspirin Br J Urol 66 1990 85 87
45. F.S. Wierod, N.J. Frandsen, and E.D. Jacobsen Risk of hemorrhage from transurethral prostatectomy in acetyl-salicylate acid and NSAID-treated patients Scand J Urol Nephrol 32 1998 120 122